My daughter was acting like she was possessed, says Kerri Archibald, whose daughter was diagnosed with PANS/PANDAS, a rare neurological condition that…
Article content
Advocates across the country are calling on provincial governments to adjust COVID-19 vaccine prioritization so cancer patients receive their second dose within four weeks rather than waiting up to 16 weeks.
Concern over a delayed second dose comes from preliminary data out of the U.K. which found people with solid cancers (a physical tumour) and blood cancers had a much lower antibody response following just one dose of the Pfizer vaccine compared to healthy people. When a second booster was given 21 days later, nearly all solid cancer patients had a much higher antibody response. This means delaying a second dose could prevent patients from having a fuller response to the vaccine and leaves them susceptible to COVID-19 while they wait for their second jab.